Danaher Officer Files Form 144 for Stock Sale
Danaher Corporation officer Matthew McGrew filed a Form 144 to propose the sale of 29,754 shares of common stock.
Stocks · News reference
Evercore ISI Adjusts Price Target on Danaher to $205 From $242
Evercore ISI has revised its price target for Danaher Corporation, lowering it from $242 to $205.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Genedata Launches New Electronic Lab Notebook Integrated into Its Platform
Genedata, a Danaher company, has introduced an electronic lab notebook (ELN) that integrates directly into its existing biopharmaceutical R&D platform.
Danaher (DHR) Upgraded to Buy: Here's Why
Danaher (DHR) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates. The industrial and medical device maker's consensus estimate for fiscal year 2026 shows a 0.8% increase over the past three months. The upgrade positions Danaher in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.